nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Nausea—Vinblastine—testicular cancer	0.00145	0.00145	CcSEcCtD
Frovatriptan—Anorexia—Cisplatin—testicular cancer	0.00144	0.00144	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00144	0.00144	CcSEcCtD
Frovatriptan—Discomfort—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Frovatriptan—Hypersensitivity—Dactinomycin—testicular cancer	0.00141	0.00141	CcSEcCtD
Frovatriptan—Confusional state—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Muscular weakness—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Abdominal pain—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Frovatriptan—Body temperature increased—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Frovatriptan—Anaphylactic shock—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Frovatriptan—Asthenia—Dactinomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Paraesthesia—Cisplatin—testicular cancer	0.00136	0.00136	CcSEcCtD
Frovatriptan—Tachycardia—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Dyspnoea—Cisplatin—testicular cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Hyperhidrosis—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Frovatriptan—Anorexia—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Frovatriptan—Decreased appetite—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Frovatriptan—Diarrhoea—Dactinomycin—testicular cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Vomiting—Bleomycin—testicular cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Depression—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Pain—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Hypersensitivity—Ifosfamide—testicular cancer	0.00129	0.00129	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Asthenia—Ifosfamide—testicular cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Feeling abnormal—Cisplatin—testicular cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Paraesthesia—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Pruritus—Ifosfamide—testicular cancer	0.00124	0.00124	CcSEcCtD
Frovatriptan—Dyspnoea—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Frovatriptan—Somnolence—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Nausea—Bleomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Frovatriptan—Vomiting—Dactinomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Frovatriptan—Decreased appetite—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Diarrhoea—Ifosfamide—testicular cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Body temperature increased—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Fatigue—Etoposide—testicular cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Pain—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Constipation—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Dizziness—Ifosfamide—testicular cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Feeling abnormal—Etoposide—testicular cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Nausea—Dactinomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Etoposide—testicular cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Vomiting—Ifosfamide—testicular cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Hypersensitivity—Cisplatin—testicular cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Abdominal pain—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Body temperature increased—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Asthenia—Cisplatin—testicular cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Chills—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Nausea—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Diarrhoea—Cisplatin—testicular cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Hypersensitivity—Etoposide—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—testicular cancer	0.000997	0.000997	CcSEcCtD
Frovatriptan—Asthenia—Etoposide—testicular cancer	0.000996	0.000996	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—testicular cancer	0.000993	0.000993	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—testicular cancer	0.000985	0.000985	CcSEcCtD
Frovatriptan—Chills—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Frovatriptan—Pruritus—Etoposide—testicular cancer	0.000982	0.000982	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—testicular cancer	0.000978	0.000978	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—testicular cancer	0.000976	0.000976	CcSEcCtD
Frovatriptan—Vomiting—Cisplatin—testicular cancer	0.000963	0.000963	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—testicular cancer	0.000953	0.000953	CcSEcCtD
Frovatriptan—Diarrhoea—Etoposide—testicular cancer	0.000949	0.000949	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—testicular cancer	0.000945	0.000945	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—testicular cancer	0.00094	0.00094	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Frovatriptan—Tension—Epirubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—testicular cancer	0.000922	0.000922	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—testicular cancer	0.000918	0.000918	CcSEcCtD
Frovatriptan—Dizziness—Etoposide—testicular cancer	0.000918	0.000918	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—testicular cancer	0.000916	0.000916	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—testicular cancer	0.000915	0.000915	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—testicular cancer	0.000905	0.000905	CcSEcCtD
Frovatriptan—Nausea—Cisplatin—testicular cancer	0.0009	0.0009	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—testicular cancer	0.000888	0.000888	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—testicular cancer	0.000882	0.000882	CcSEcCtD
Frovatriptan—Vomiting—Etoposide—testicular cancer	0.000882	0.000882	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Frovatriptan—Headache—Etoposide—testicular cancer	0.000869	0.000869	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—testicular cancer	0.000867	0.000867	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—testicular cancer	0.000867	0.000867	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—testicular cancer	0.000867	0.000867	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—testicular cancer	0.000865	0.000865	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—testicular cancer	0.000857	0.000857	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—testicular cancer	0.000856	0.000856	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—testicular cancer	0.000853	0.000853	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—testicular cancer	0.000842	0.000842	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—testicular cancer	0.000838	0.000838	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—testicular cancer	0.000838	0.000838	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—testicular cancer	0.000831	0.000831	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—testicular cancer	0.000826	0.000826	CcSEcCtD
Frovatriptan—Nausea—Etoposide—testicular cancer	0.000824	0.000824	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—testicular cancer	0.000804	0.000804	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—testicular cancer	0.000802	0.000802	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—testicular cancer	0.000794	0.000794	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—testicular cancer	0.000792	0.000792	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—testicular cancer	0.000792	0.000792	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—testicular cancer	0.000784	0.000784	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—testicular cancer	0.000775	0.000775	CcSEcCtD
Frovatriptan—Shock—Epirubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—testicular cancer	0.000764	0.000764	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000757	0.000757	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—testicular cancer	0.000752	0.000752	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—testicular cancer	0.000746	0.000746	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—testicular cancer	0.000742	0.000742	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—testicular cancer	0.000741	0.000741	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—testicular cancer	0.000739	0.000739	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—testicular cancer	0.000732	0.000732	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—testicular cancer	0.000726	0.000726	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—testicular cancer	0.000723	0.000723	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—testicular cancer	0.000717	0.000717	CcSEcCtD
Frovatriptan—Pain—Methotrexate—testicular cancer	0.000711	0.000711	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000709	0.000709	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—testicular cancer	0.000704	0.000704	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—testicular cancer	0.000685	0.000685	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—testicular cancer	0.00068	0.00068	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Frovatriptan—Pain—Epirubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—testicular cancer	0.000657	0.000657	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—testicular cancer	0.000657	0.000657	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000656	0.000656	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—testicular cancer	0.000612	0.000612	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—testicular cancer	0.000596	0.000596	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000589	0.000589	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—testicular cancer	0.000588	0.000588	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—testicular cancer	0.000569	0.000569	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—testicular cancer	0.00055	0.00055	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—testicular cancer	0.00053	0.00053	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—testicular cancer	0.000528	0.000528	CcSEcCtD
Frovatriptan—Headache—Methotrexate—testicular cancer	0.000521	0.000521	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—testicular cancer	0.000514	0.000514	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—testicular cancer	0.000509	0.000509	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—testicular cancer	0.000494	0.000494	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Frovatriptan—Headache—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—testicular cancer	0.000428	0.000428	CcSEcCtD
